| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1169679
[patent_doc_number] => 06753320
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'LIF for use in modulating inflammation and pain'
[patent_app_type] => B1
[patent_app_number] => 09/712028
[patent_app_country] => US
[patent_app_date] => 2000-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 15271
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753320.pdf
[firstpage_image] =>[orig_patent_app_number] => 09712028
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/712028 | LIF for use in modulating inflammation and pain | Nov 12, 2000 | Issued |
Array
(
[id] => 1265861
[patent_doc_number] => 06660904
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-09
[patent_title] => 'HIV and CD4 transgenic animals and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/685256
[patent_app_country] => US
[patent_app_date] => 2000-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 22433
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/660/06660904.pdf
[firstpage_image] =>[orig_patent_app_number] => 09685256
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/685256 | HIV and CD4 transgenic animals and uses therefor | Oct 9, 2000 | Issued |
| 09/685666 | COMPOSITIONS AND METHODS OF MAKING SPERMATOGONIAL STEM CELLS | Oct 9, 2000 | Abandoned |
Array
(
[id] => 7964461
[patent_doc_number] => 06680196
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-20
[patent_title] => 'Gene that is amplified and overexpressed in cancer and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/647143
[patent_app_country] => US
[patent_app_date] => 2000-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 16838
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680196.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647143
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647143 | Gene that is amplified and overexpressed in cancer and methods of use thereof | Sep 26, 2000 | Issued |
Array
(
[id] => 1083188
[patent_doc_number] => 06833489
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-21
[patent_title] => 'Assays for modulators of prolyl-4-hydroxylase'
[patent_app_type] => B1
[patent_app_number] => 09/663805
[patent_app_country] => US
[patent_app_date] => 2000-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3169
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/833/06833489.pdf
[firstpage_image] =>[orig_patent_app_number] => 09663805
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/663805 | Assays for modulators of prolyl-4-hydroxylase | Sep 14, 2000 | Issued |
Array
(
[id] => 948661
[patent_doc_number] => 06962696
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-08
[patent_title] => 'Compositions and methods for tumor-targeted delivery of effector molecules'
[patent_app_type] => utility
[patent_app_number] => 09/645415
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 47200
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/962/06962696.pdf
[firstpage_image] =>[orig_patent_app_number] => 09645415
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645415 | Compositions and methods for tumor-targeted delivery of effector molecules | Aug 23, 2000 | Issued |
Array
(
[id] => 1265365
[patent_doc_number] => 06656449
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Methods of screening agents for activity using teleosts'
[patent_app_type] => B1
[patent_app_number] => 09/645432
[patent_app_country] => US
[patent_app_date] => 2000-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 29
[patent_no_of_words] => 37449
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656449.pdf
[firstpage_image] =>[orig_patent_app_number] => 09645432
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645432 | Methods of screening agents for activity using teleosts | Aug 22, 2000 | Issued |
| 09/622490 | Transgenic mouse having a lacz reporter gene under the control of the n-cam promoter useful for identifying n-cam modulators, methods and compositions | Aug 16, 2000 | Abandoned |
Array
(
[id] => 1164100
[patent_doc_number] => 06759393
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-06
[patent_title] => 'Growth hormone and growth hormone releasing hormone compositions'
[patent_app_type] => B1
[patent_app_number] => 09/628730
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23791
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759393.pdf
[firstpage_image] =>[orig_patent_app_number] => 09628730
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/628730 | Growth hormone and growth hormone releasing hormone compositions | Jul 27, 2000 | Issued |
| 09/509668 | TRANSGENIC MODEL COMPRISING TCR ALPHA AND BETA CHAINS | Jul 24, 2000 | Abandoned |
| 09/446808 | MAMMAL WITH INHIBITION OF THE POLY(ADP RIBOSE) POLYMERASE AND METHOD FOR USING SAME TO IDENTIFY CANCERIGENIC AGENTS | Jul 20, 2000 | Abandoned |
Array
(
[id] => 1049977
[patent_doc_number] => 06861254
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-01
[patent_title] => 'Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 09/557262
[patent_app_country] => US
[patent_app_date] => 2000-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24867
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/861/06861254.pdf
[firstpage_image] =>[orig_patent_app_number] => 09557262
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/557262 | Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor | Apr 23, 2000 | Issued |
| 09/485015 | Insect control gene dsf and methods of use | Apr 13, 2000 | Abandoned |
| 09/513575 | COMPOSITIONS AND METHODS FOR NON-TARGETED ACTIVATION OF ENDOGENOUS GENES | Feb 24, 2000 | Abandoned |
| 09/496499 | Compositions and methods for treating lysosomal storage disease | Feb 1, 2000 | Abandoned |
Array
(
[id] => 1397335
[patent_doc_number] => 06545198
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Transgenically produced prolactin'
[patent_app_type] => B1
[patent_app_number] => 09/490657
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17838
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/545/06545198.pdf
[firstpage_image] =>[orig_patent_app_number] => 09490657
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490657 | Transgenically produced prolactin | Jan 23, 2000 | Issued |
Array
(
[id] => 1410430
[patent_doc_number] => 06524818
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/484997
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 98
[patent_no_of_words] => 62557
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/524/06524818.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484997
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484997 | Compositions and methods for non-targeted activation of endogenous genes | Jan 17, 2000 | Issued |
Array
(
[id] => 1299220
[patent_doc_number] => 06623958
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-23
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/484996
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 62543
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/623/06623958.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484996
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484996 | Compositions and methods for non-targeted activation of endogenous genes | Jan 17, 2000 | Issued |
Array
(
[id] => 1179533
[patent_doc_number] => 06740503
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-25
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/484317
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 62558
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740503.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484317
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484317 | Compositions and methods for non-targeted activation of endogenous genes | Jan 17, 2000 | Issued |
Array
(
[id] => 1410556
[patent_doc_number] => 06524824
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/481355
[patent_app_country] => US
[patent_app_date] => 2000-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 62555
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/524/06524824.pdf
[firstpage_image] =>[orig_patent_app_number] => 09481355
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481355 | Compositions and methods for non-targeted activation of endogenous genes | Jan 11, 2000 | Issued |